| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
TNF receptor superfamily member 10b | 0.505 | 0.769 | 2.0E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2001 | 2008 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2011 | ||||||||
|
bone morphogenetic protein 6 | 0.531 | 0.808 | 0.76 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.170 | None | 0.857 | 1 | 0 | 1995 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2008 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
CASP8 and FADD like apoptosis regulator | 0.485 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.965 | 4 | 0 | 1995 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.833 | 3 | 0 | 1994 | 2019 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.380 | None | 1.000 | 3 | 0 | 2005 | 2017 | ||||||||
|
neurofibromin 2 | 0.468 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2011 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2001 | 2009 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.330 | None | 0.667 | 1 | 0 | 2008 | 2016 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2012 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2004 | 2014 |